Delix Therapeutics
company
About
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $70M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale.The company was founded in 2019 and is headquartered in Boston, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$70M
Delix Therapeutics has raised a total of
$70M
in funding over 2 rounds. Their latest funding was raised on
Sep 27, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2021 | Series A | $70M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
